Pfizer Recalls Children’s Advil
Pfizer Consumer Healthcare is recalling one lot of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle because of improperly marked dosage cups.
On Aug. 27, 2018, Pfizer Consumer Healthcare, a division of Pfizer Inc., announced it was voluntarily recalling one lot of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle. The recall was initiated after customers complained that the dosage cup provided is marked in teaspoons but the instructions on the label are described in milliliters (mL). The recalled product, NDC 0573-0207-30, lot R51129, was distributed nationwide from May–June 2018.
Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle temporarily reduces fever and relieves minor aches and pains due to the common cold, flu, sore throat, headaches and toothaches. According to the company, the difference in measurements listed may potentially result in an overdose, which could cause nausea, vomiting, headache, drowsiness, blurred vision, and dizziness.
Source: FDA
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
